Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
GOSR2 Biologics Sequence Review Report 2026: Golgi SNAP receptor complex member 2 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of GOSR2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
PEX7 Biologics Sequence Review Report 2026: Peroxisomal targeting signal 2 receptor Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of PEX7 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
GABRP Biologics Sequence Review Report 2026: Gamma-aminobutyric acid receptor subunit pi Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of GABRP protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
PITPNM1 Biologics Sequence Review Report 2026: Membrane-associated phosphatidylinositol transfer protein 1 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of PITPNM1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
CD1E Biologics Sequence Review Report 2026: T-cell surface glycoprotein CD1e, membrane-associated Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of CD1E protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
8 min read
CD99 Biologics Sequence Review Report 2026: CD99 antigen Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of CD99 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
CD8B Biologics Sequence Review Report 2026: T-cell surface glycoprotein CD8 beta chain Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of CD8B protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
8 min read
NR5A2 Biologics Sequence Review Report 2026: Nuclear receptor subfamily 5 group A member 2 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of NR5A2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
GFRA2 Biologics Sequence Review Report 2026: GDNF family receptor alpha-2 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of GFRA2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
BMAL1 Biologics Sequence Review Report 2026: Basic helix-loop-helix ARNT-like protein 1 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of BMAL1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
PGRMC1 Biologics Sequence Review Report 2026: Membrane-associated progesterone receptor component 1 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of PGRMC1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
GET1 Biologics Sequence Review Report 2026: Guided entry of tail-anchored proteins factor 1 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of GET1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.